Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

163.96
Delayed Data
As of Sep 22
 +4.17 / +2.61%
Today’s Change
95.14
Today|||52-Week Range
164.60
+45.51%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close159.79
Today’s open160.01
Day’s range159.51 - 164.60
Volume355,780
Average volume (3 months)309,866
Market cap$7.0B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+84.81%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+35.13%
P/E ratio96.4
Price/Sales12.56
Price/Book15.44

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.49+0.71%
WSTWest Pharmaceutical ...+1.08+1.15%
MASIMasimo Corp+0.07+0.08%
IARTIntegra LifeSciences...+0.62+1.28%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts